Pharmacist Salary by State (2026): PharmD Pay Compared Across All 50 States

Pharmacist salary by state varies meaningfully across the U.S. — the spread reflects state-level pharmacy school graduate supply, state collaborative-practice-agreement and provider-status laws, the regional balance between retail community pharmacy and hospital clinical pharmacy, and the local concentration of specialty pharmacy and federal facilities. The national median for Pharmacists sits at $143,489, but state-by-state pay across the 52 states tracked here ranges widely — from $113,848 in Puerto Rico to $169,291 in Oregon.

This page compares the average pharmacist salary by state across 1690+ metropolitan and non-metropolitan areas — drawing on the Bureau of Labor Statistics Occupational Employment and Wage Statistics (OEWS) survey for SOC 29-1051. If you're a working PharmD evaluating relocation, a P4 student planning your first APPE/residency placement, or a pharmacy director benchmarking pay across states, the state-level comparison below is the central reference point.

How Pharmacist Salary by State Is Measured

The BLS reports state-level pharmacist salary through three numbers:

• Annual median (50th percentile) — used to rank state-level pay in the table below.
• Annual mean (average) — typically runs 3–5% above median; states with strong specialty pharmacy, ambulatory clinical, and BPS-credentialed specialist concentration show wider mean-median spreads.
• Percentile distribution (P10 / P25 / P75 / P90) — P10 reflects entry-level retail community pharmacists; P90 reflects BPS-board-certified clinical specialists (BCPS, BCOP, BCACP, BCPP, BCCCP, BCNSP, BCIDP), pharmacy managers and directors, specialty pharmacy clinical pharmacists, and independent owner-operators.

The state-comparison table below applies BEA Regional Price Parity (RPP) adjustment so both nominal pay and real purchasing power are visible.

1. State Pharmacy School Supply and Market Saturation

The single largest non-cost-of-living driver of state-level pharmacist pay is local PharmD graduate supply. States with multiple ACPE-accredited pharmacy schools have larger graduate pipelines, which can compress retail community pharmacist pay in oversupplied metros — though clinical and specialty pharmacy roles remain competitive in those same states:

• High-pharmacy-school-density states — California, Texas, Florida, New York, Pennsylvania, Ohio, North Carolina, Massachusetts, Illinois host multiple ACPE-accredited PharmD programs. Retail base pay in oversupplied metros within these states tends to compress; clinical and specialty roles remain competitive.
• Low-pharmacy-school-supply states — Mountain West (Wyoming, Idaho, Alaska, Montana, North Dakota, South Dakota), parts of Hawaii, and rural states show structural pharmacist supply shortages. These states routinely offer $15,000–$50,000 sign-on bonuses, paid relocation, and federal student-loan repayment through the NHSC for clinical-pharmacy roles.
• Retail community pharmacy pay pressure — chains (CVS, Walgreens, Walmart, Kroger, Rite Aid) have closed stores aggressively over the past several years. States with the largest retail store closures (Pennsylvania, California, Indiana, Tennessee, Ohio) face compressed retail base pay despite high cost of living in some cases.

2. State Scope of Practice and Provider Status

State pharmacy practice laws materially affect state-level pharmacist pay because broader scope creates more billable clinical service opportunities:

• State collaborative practice agreement (CPA) authority — most states allow pharmacists to enter CPAs with physicians for medication therapy management, but breadth varies. States with broad CPA scope (California, Washington, Oregon, North Carolina, New Mexico, Idaho, Montana) support stronger clinical pharmacy hiring and pay.
• State pharmacist provider status — some states (California, Washington, Oregon, Idaho, New Mexico, Arizona) recognize pharmacists as providers for Medicaid billing, supporting independent practice and consulting income.
• State point-of-care testing authority — states permitting pharmacist-administered point-of-care testing (strep, flu, COVID, HIV, hepatitis C) expand pharmacy revenue and indirectly support pharmacist pay.
• State hormonal contraception and immunization scope — states allowing pharmacist-prescribed hormonal contraception (California, Oregon, Washington, Colorado, Arizona, New Mexico, Hawaii, Utah, Tennessee) and broad pharmacist immunization scope support specialty service revenue.
• State independent prescribing for minor conditions — emerging in some states; expands pharmacist scope significantly.

3. State Demand-Supply Dynamics for Pharmacists

State-level pharmacist pay reflects the demand-supply balance:

• State health-system clinical pharmacy density — Massachusetts, Maryland, Pennsylvania, Minnesota, Texas, North Carolina, California, Ohio concentrate large not-for-profit health systems with structured clinical pharmacy programs (anticoagulation, transitions of care, ID stewardship, oncology). These states drive upper-percentile clinical pharmacist pay.
• State specialty pharmacy concentration — Tennessee (Express Scripts subsidiary), Texas, Florida, California, Pennsylvania, North Carolina concentrate specialty pharmacy operations (CVS Caremark Specialty, Walgreens Specialty Pharmacy, Accredo, Diplomat). Specialty pharmacy roles pay above retail baseline.
• State federal pharmacy concentration — Texas (multiple VA medical centers + DoD bases), California (multiple VA + USPHS), Maryland (VA + USPHS HQ + NIH), Virginia (VA + USPHS + DoD), and other states with major federal medical center concentration support stable federal pharmacist roles with strong pension and PSLF eligibility.
• State HPSA concentration — rural Mountain West, Deep South, and Appalachian states with high health professional shortage area concentration offer NHSC plus state-level loan repayment programs for clinical pharmacists.
• State Medicare Advantage and Medicaid expansion — states with strong MA penetration and Medicaid expansion (California, New York, Massachusetts, Pennsylvania, Michigan, Illinois) support expanded clinical pharmacy roles through Medication Therapy Management (MTM) programs.

4. BPS Specialty Credentials and State-Level Pay Distribution

The Board of Pharmacy Specialties (BPS) issues 14 specialty certifications. Distribution by state shapes upper-percentile state pharmacist pay:

• BCPS (Pharmacotherapy Specialist) — most widely held; uniform distribution across states.
• BCOP (Oncology) — concentrated at NCI-designated cancer center states (Texas, Maryland, Massachusetts, New York, Pennsylvania, California, Ohio).
• BCACP (Ambulatory Care) — concentrated at states with strong ambulatory care pharmacy programs (Minnesota, North Carolina, Maryland, California, Washington).
• BCPP (Psychiatric Pharmacist) — niche specialty at major psychiatric markets.
• BCCCP (Critical Care) — concentrated at Level-1 trauma center states.
• BCIDP (Infectious Diseases) — concentrated at academic medical center states.
• BCNSP, BCGP, BCNP, BCSCP, BCPPS, BCTXP, BCCP, BCEMP — additional specialty credentials at corresponding markets.

How to Compare Pharmacist Salary by State Effectively

When comparing the average pharmacist salary by state, work through this checklist:

• Compare nominal and real (cost-adjusted) pay together — a state with the highest nominal median can have lower real purchasing power if its cost of living is higher.
• Check state income tax — pharmacists in Texas, Florida, Tennessee, Nevada, Washington, Wyoming, South Dakota, Alaska, and New Hampshire keep more of every dollar. State income tax savings can reach $8,000–$15,000 annually for senior pharmacists.
• Verify state pharmacy school supply — high-pharmacy-school-density states (CA, TX, FL, NY, PA, OH, NC, MA, IL) have compressed retail pay in oversupplied metros.
• Check state CPA and provider-status authority — states with broad CPA scope and pharmacist provider status support stronger clinical and ambulatory care roles.
• Compare percentile distribution, not just median — states with strong specialty pharmacy and BPS credential density show wider P75–P90 spreads.
• Factor in employer mix — retail-heavy states have compressed lower percentiles; hospital and specialty pharmacy states support upper percentiles.
• Consider rural shortage opportunities — Mountain West and rural states offer substantial sign-on bonuses plus NHSC loan repayment.

2026 State-Level Pharmacist Salary Outlook

Pharmacist pay has grown at a compound annual rate of 1.83% nationally over the past five years — slower than other healthcare professions in retail community pharmacy, faster in clinical, specialty, and ambulatory care settings. States with rapid specialty pharmacy expansion (Tennessee, Texas, Florida, North Carolina), states with broad pharmacist provider status and CPA scope (California, Washington, Oregon, Idaho, North Carolina, New Mexico), and rural shortage states using NHSC plus state programs to recruit (Montana, Wyoming, North Dakota, Alaska, West Virginia) are seeing the fastest state-level pay growth through 2026. The BLS projects Pharmacists employment growth at 5% through 2033, with growth concentrated in hospital, specialty, and clinical-ambulatory settings rather than retail community.

Browse the state-by-state comparison table below to see the $143,489-baseline state ranking, top 10 and bottom 10 states by projected median, regional groupings (Northeast / Midwest / South / West), and direct links to per-state pages for deeper city-level breakdown.